Erectile dysfunction – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 19 Jun 2026 04:02:56 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Erectile dysfunction – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study of Sildenafil for Men with Erectile Dysfunction to Evaluate Their Ability to Safely Decide on Using This Medication Independently https://clinicaltrials.eu/trial/study-of-sildenafil-for-men-with-erectile-dysfunction-to-evaluate-their-ability-to-safely-decide-on-using-this-medication-independently/ Wed, 29 Apr 2026 15:08:07 +0000 https://clinicaltrials.eu/trial/study-of-sildenafil-for-men-with-erectile-dysfunction-to-evaluate-their-ability-to-safely-decide-on-using-this-medication-independently/ This study examines erectile dysfunction, which is a condition where men have difficulty achieving or maintaining an erection sufficient for sexual activity. The treatment being evaluated in this study is sildenafil 100 mg, which is provided as film-coated tablets taken by mouth. The purpose of the study is to assess whether participants can independently make safe decisions about whether it is appropriate for them to use this medication using a dedicated diagnostic tool.

During the study, participants will use the diagnostic tool to help them determine if it is safe for them to take the medication. The study will look at how well participants follow the prescribed way of taking the medicine, whether the medication is effective in allowing them to achieve and maintain an erection sufficient for sexual intercourse, and how many sexual encounters are satisfactory after taking the medication. The study will also monitor any unwanted effects that may occur during the treatment period, which can last up to 42 days.

This is a multicenter study, meaning it will take place at several different locations. Participants will be adult men who are sexually active and planning to have sexual interactions. Throughout the study, information will be collected about how participants use the medication and their experiences with it to understand if they can safely manage their treatment independently.

]]> Study on the Effectiveness of Platelet Concentrate and Shockwave Therapy for Men with Mild to Moderate Erectile Dysfunction https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-platelet-concentrate-and-shockwave-therapy-for-men-with-mild-to-moderate-erectile-dysfunction/ Wed, 29 Apr 2026 15:00:32 +0000 https://clinicaltrials.eu/trial/study-on-the-effectiveness-of-platelet-concentrate-and-shockwave-therapy-for-men-with-mild-to-moderate-erectile-dysfunction/ This clinical trial is focused on studying the treatment of erectile dysfunction, a condition where a man has difficulty achieving or maintaining an erection. The treatment being tested involves the use of Platelet Concentrate, which is a solution made from a person’s own blood. This solution is injected locally to help improve the condition. The study also includes the use of Focal Shockwave Therapy, a technique that uses sound waves to stimulate blood flow and tissue repair in the affected area.

The purpose of the study is to evaluate how effective and safe this combined treatment is for men with moderate or mild to moderate erectile dysfunction. Participants will receive either the treatment or a placebo. The study will last for several weeks, during which participants will receive injections and undergo shockwave therapy. The effectiveness of the treatment will be assessed by improvements in a questionnaire that measures erectile function.

Throughout the study, participants will be monitored for any side effects related to the treatment. The goal is to determine if this approach can significantly improve erectile function and overall sexual quality of life. The study will also track changes in the ability to achieve vaginal penetration and any improvements in sexual satisfaction over time.

]]> Study of Botulinum Toxin and Saline Solution for Erectile Dysfunction in Patients Unresponsive to Standard Treatments https://clinicaltrials.eu/trial/study-of-botulinum-toxin-and-saline-solution-for-erectile-dysfunction-in-patients-unresponsive-to-standard-treatments/ Wed, 29 Apr 2026 14:59:13 +0000 https://clinicaltrials.eu/trial/study-of-botulinum-toxin-and-saline-solution-for-erectile-dysfunction-in-patients-unresponsive-to-standard-treatments/ This clinical trial is focused on studying a new treatment for erectile dysfunction, a condition where a man has difficulty achieving or maintaining an erection. The study is testing the effectiveness of a medication called Onabotulinumtoxin A, which is a type of botulinum toxin. This medication will be injected directly into the corpora cavernosa, which are the sponge-like regions of the penis that fill with blood to create an erection. The trial aims to see if this treatment can help men who have not responded well to other treatments, such as phosphodiesterase-5 inhibitors, which are commonly used medications for erectile dysfunction.

Participants in the study will receive either the Onabotulinumtoxin A injection or a placebo. The study is designed to be double-blind, meaning neither the participants nor the researchers will know who is receiving the actual medication and who is receiving the placebo. This helps ensure that the results are not biased. The main goal of the study is to determine if the injections improve the subjective perception of rigidity, which refers to how firm the erection feels to the participant.

The study will take place over a period of time, with participants required to attend follow-up appointments and undergo certain tests to monitor their progress. The trial is expected to start recruiting participants in 2024 and aims to conclude by 2026. This research could potentially offer a new option for men with erectile dysfunction who have not found success with existing treatments.

]]> Study on the Safety and Effectiveness of LIB-01 for Treating Erectile Dysfunction in Adult Men https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-lib-01-for-treating-erectile-dysfunction-in-adult-men/ Wed, 29 Apr 2026 14:23:05 +0000 https://clinicaltrials.eu/trial/study-on-the-safety-and-effectiveness-of-lib-01-for-treating-erectile-dysfunction-in-adult-men/ This clinical trial is focused on studying the treatment of erectile dysfunction (ED), a condition where a man has difficulty achieving or maintaining an erection. The treatment being tested is called LIB-01 MONOHYDRATE, which is a powder that is mixed with liquid to create an oral suspension. This means it is taken by mouth. The trial will also include a placebo group to compare the effects of the treatment.

The purpose of the study is to evaluate how effective and safe LIB-01 is for treating erectile dysfunction. Participants in the study will be randomly assigned to receive either the treatment or a placebo. The study is designed to be double-blind, meaning neither the participants nor the researchers will know who is receiving the actual treatment or the placebo. This helps ensure that the results are not biased. The study will last for a period of up to three weeks, during which participants will take the treatment or placebo and attend regular check-ups to monitor their progress and any side effects.

Throughout the study, participants will be asked to complete questionnaires about their erectile function and overall satisfaction. The main goal is to see if there is an improvement in erectile function after taking LIB-01 compared to the placebo. Safety will also be closely monitored by checking for any adverse effects, changes in vital signs, and other health indicators. The study aims to provide valuable information on whether LIB-01 can be a safe and effective treatment option for men with erectile dysfunction.

]]>